Quince Therapeutics Inc. (QNCX)
1.46
0.01 (0.69%)
At close: Mar 03, 2025, 3:59 PM
1.57
7.53%
Pre-market: Mar 04, 2025, 07:00 AM EST
Quince Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 20.75M | 44.58M | 69.72M | 66.84M | 51.21M | 24.87M | 7.34M |
| Short-Term Investments | 54.31M | 45.6M | 37.08M | 66.98M | 48.65M | 46.84M | n/a |
| Long-Term Investments | 78K | 3.58M | 19.93M | 50.46M | 16.76M | n/a | n/a |
| Other Long-Term Assets | 8.47M | -1.03M | 194K | 39K | 217K | 10K | 59K |
| Receivables | 993K | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | 2.29M | 2.25M | n/a | n/a | n/a | n/a |
| Other Current Assets | 1.39M | 3.57M | 4.87M | 4.04M | 6.19M | 868K | 194K |
| Total Current Assets | 77.44M | 93.75M | 111.67M | 137.86M | 106.06M | 72.58M | 7.54M |
| Property-Plant & Equipment | 619K | 684K | 1.43M | 1.1M | 1.33M | 283K | 122K |
| Goodwill & Intangibles | 81.3M | 5.9M | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 90.46M | 10.16M | 21.55M | 51.6M | 18.31M | 293K | 181K |
| Total Assets | 167.9M | 103.91M | 133.23M | 189.47M | 124.37M | 72.88M | 7.72M |
| Account Payables | 2.03M | 570K | 4.91M | 3.56M | 3.08M | 495K | 517K |
| Deferred Revenue | n/a | n/a | 8.39M | -238K | n/a | n/a | n/a |
| Short-Term Debt | 64K | 453K | 741K | 238K | n/a | n/a | n/a |
| Other Current Liabilities | 7.47M | 2.05M | 8.57M | 13.2M | 5.82M | 962K | 1.25M |
| Total Current Liabilities | 9.57M | 3.07M | 14.22M | 17M | 8.89M | 1.46M | 1.76M |
| Long-Term Debt | 13.75M | n/a | 420K | 208K | n/a | n/a | 7.17M |
| Other Long-Term Liabilities | 54.19M | n/a | n/a | n/a | n/a | n/a | 19.06M |
| Total Long-Term Liabilities | 73.24M | 248K | 420K | 208K | n/a | 495K | 26.23M |
| Total Liabilities | 82.82M | 3.32M | 14.64M | 17.2M | 8.89M | 1.46M | 28M |
| Total Debt | 13.81M | 453K | 1.16M | 208K | n/a | n/a | 7.17M |
| Common Stock | 43K | 36K | 30K | 29K | 27K | 22K | 3K |
| Retained Earnings | -319.64M | -288.26M | -236.6M | -146.65M | -69.81M | -32.83M | -20.35M |
| Comprehensive Income | 3.05M | -289K | -79K | 313K | 60K | -49K | -17.18M |
| Shareholders Equity | 85.08M | 100.59M | 118.59M | 172.26M | 115.48M | 71.42M | -20.28M |
| Total Investments | 54.38M | 49.18M | 57.01M | 117.44M | 65.41M | 46.84M | n/a |